Literature DB >> 16949319

Fast quantification of proton magnetic resonance spectroscopic imaging with artificial neural networks.

Himanshu Bhat1, Balasrinivasa Rao Sajja, Ponnada A Narayana.   

Abstract

Accurate quantification of the MRSI-observed regional distribution of metabolites involves relatively long processing times. This is particularly true in dealing with large amount of data that is typically acquired in multi-center clinical studies. To significantly shorten the processing time, an artificial neural network (ANN)-based approach was explored for quantifying the phase corrected (as opposed to magnitude) spectra. Specifically, in these studies radial basis function neural network (RBFNN) was used. This method was tested on simulated and normal human brain data acquired at 3T. The N-acetyl aspartate (NAA)/creatine (Cr), choline (Cho)/Cr, glutamate+glutamine (Glx)/Cr, and myo-inositol (mI)/Cr ratios in normal subjects were compared with the line fitting (LF) technique and jMRUI-AMARES analysis, and published values. The average NAA/Cr, Cho/Cr, Glx/Cr and mI/Cr ratios in normal controls were found to be 1.58+/-0.13, 0.9+/-0.08, 0.7+/-0.17 and 0.42+/-0.07, respectively. The corresponding ratios using the LF and jMRUI-AMARES methods were 1.6+/-0.11, 0.95+/-0.08, 0.78+/-0.18, 0.49+/-0.1 and 1.61+/-0.15, 0.78+/-0.07, 0.61+/-0.18, 0.42+/-0.13, respectively. These results agree with those published in literature. Bland-Altman analysis indicated an excellent agreement and minimal bias between the results obtained with RBFNN and other methods. The computational time for the current method was 15s compared to approximately 10 min for the LF-based analysis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16949319      PMCID: PMC1752214          DOI: 10.1016/j.jmr.2006.08.004

Source DB:  PubMed          Journal:  J Magn Reson        ISSN: 1090-7807            Impact factor:   2.229


  34 in total

Review 1.  Proton magnetic resonance spectroscopy in the brain: report of AAPM MR Task Group #9.

Authors:  Dick J Drost; William R Riddle; Geoffrey D Clarke
Journal:  Med Phys       Date:  2002-09       Impact factor: 4.071

Review 2.  Magnetic resonance spectroscopy in the monitoring of multiple sclerosis.

Authors:  Ponnada A Narayana
Journal:  J Neuroimaging       Date:  2005       Impact factor: 2.486

3.  Automated classification of human brain tumours by neural network analysis using in vivo 1H magnetic resonance spectroscopic metabolite phenotypes.

Authors:  J P Usenius; S Tuohimetsä; P Vainio; M Ala-Korpela; Y Hiltunen; R A Kauppinen
Journal:  Neuroreport       Date:  1996-07-08       Impact factor: 1.837

4.  Automated spectral analysis II: application of wavelet shrinkage for characterization of non-parameterized signals.

Authors:  K Young; B J Soher; A A Maudsley
Journal:  Magn Reson Med       Date:  1998-12       Impact factor: 4.668

5.  Improved method for accurate and efficient quantification of MRS data with use of prior knowledge

Authors: 
Journal:  J Magn Reson       Date:  1997-11       Impact factor: 2.229

6.  Correction of phase effects produced by eddy currents in solvent suppressed 1H-CSI.

Authors:  J R Roebuck; D O Hearshen; M O'Donnell; T Raidy
Journal:  Magn Reson Med       Date:  1993-09       Impact factor: 4.668

Review 7.  Proton MRS in neurological disorders.

Authors:  S Bonavita; F Di Salle; G Tedeschi
Journal:  Eur J Radiol       Date:  1999-05       Impact factor: 3.528

8.  Grey matter abnormalities in multiple sclerosis: proton magnetic resonance spectroscopic imaging.

Authors:  R Sharma; P A Narayana; J S Wolinsky
Journal:  Mult Scler       Date:  2001-08       Impact factor: 6.312

9.  Proton MR spectroscopic study at 3 Tesla on glutamate/glutamine in Alzheimer's disease.

Authors:  Noriaki Hattori; Kazuo Abe; Saburo Sakoda; Tohru Sawada
Journal:  Neuroreport       Date:  2002-01-21       Impact factor: 1.837

10.  Use of Voigt lineshape for quantification of in vivo 1H spectra.

Authors:  I Marshall; J Higinbotham; S Bruce; A Freise
Journal:  Magn Reson Med       Date:  1997-05       Impact factor: 4.668

View more
  6 in total

1.  Artificial neural networks for classification in metabolomic studies of whole cells using 1H nuclear magnetic resonance.

Authors:  D F Brougham; G Ivanova; M Gottschalk; D M Collins; A J Eustace; R O'Connor; J Havel
Journal:  J Biomed Biotechnol       Date:  2010-09-15

2.  Spectral resolution amelioration by deconvolution (SPREAD) in MR spectroscopic imaging.

Authors:  Zhengchao Dong; Bradley S Peterson
Journal:  J Magn Reson Imaging       Date:  2009-06       Impact factor: 4.813

Review 3.  Proton magnetic resonance spectroscopy in multiple sclerosis.

Authors:  Balasrinivasa R Sajja; Jerry S Wolinsky; Ponnada A Narayana
Journal:  Neuroimaging Clin N Am       Date:  2009-02       Impact factor: 2.264

4.  Incorporation of a spectral model in a convolutional neural network for accelerated spectral fitting.

Authors:  Saumya S Gurbani; Sulaiman Sheriff; Andrew A Maudsley; Hyunsuk Shim; Lee A D Cooper
Journal:  Magn Reson Med       Date:  2019-01-21       Impact factor: 4.668

5.  N-acetyl-aspartyl-glutamate detection in the human brain at 7 Tesla by echo time optimization and improved Wiener filtering.

Authors:  Li An; Shizhe Li; Emily T Wood; Daniel S Reich; Jun Shen
Journal:  Magn Reson Med       Date:  2013-11-14       Impact factor: 4.668

6.  Advanced magnetic resonance spectroscopic neuroimaging: Experts' consensus recommendations.

Authors:  Andrew A Maudsley; Ovidiu C Andronesi; Peter B Barker; Alberto Bizzi; Wolfgang Bogner; Anke Henning; Sarah J Nelson; Stefan Posse; Dikoma C Shungu; Brian J Soher
Journal:  NMR Biomed       Date:  2020-04-29       Impact factor: 4.044

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.